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Abstract
Solid pseudopapillary neoplasms are rare and represent
approximately 4% of all cystic pancreatic tumours, and
predominately affect females. They have an excellent
prognosis, however 10-15% of the patients show
metastasis at the time of surgery or recurrence of tumour
during follow-up after pancreatectomy. Surgical resection
is the recommended treatment.
We present a rare case of a 15-year-old female, with a
pseudopapillary tumour of the pancreas which was
diagnosed pre-operatively.
Keywords: Pseudopapillary neoplasm, Surgery, Pancreas.
DOI: https://doi.org/10.47391/JPMA.05-746
Introduction
The solid pseudopapillary neoplasm (SPN) of the pancreas,
also known as a papillary-cystic tumour or Frantz tumour,
is a distinct epithelial neoplasm of unfamiliar origin. Solid
pseudo papillary neoplasm of the pancreas is a low-grade
malignant tumour derived from exocrine cells and
composed of poorly cohesive epithelial cells, forming solid
and pseudopapillary arrangement and lacking a specific
line of pancreatic epithelial differentiation.1 In adult
population it accounts for approximately 2% to 3% of
pancreatic neoplasms but differs from other pancreatic
tumours by a female predominance and a low risk of
malignancy. SPN for the most part occurs in the younger
population and occasionally in children, contrary to other
pancreatic carcinomas. It also seems to have a predilection
for Asian and African American women.2
It is a rare pancreatic tumour, usually presenting with a
palpable abdominal mass. It is commonly seen in females,
presenting during their second or fourth decade of life.
Due to advances in diagnostic techniques, there has been
a recent increase in the number of cases of these pancreatic
tumours. The tumour differentiation is important from
other neoplasms of the pancreas because complete
resection is curative in many cases and provides a chance
of long-term survival.3
We present the case of a 15-year-old girl with
pseudopapillary tumour of the pancreas. She underwent
complete surgical resection. 
Case Presentation
A 15-year-old girl presented to our outpatient department
at Aga Khan university hospital, with complaints of left
lumbar pain for the past one month and fatigability and
weight loss. 
Abdominal examination revealed a palpable mass in the
left upper quadrant; however, the rest of the examination
was unremarkable. Investigations revealed an elevated
LDH levels of 324gm/L. Ultrasound of the abdomen
showed a 13.1x14.3cm well-circumscribed cystic and solid
mass in the upper abdomen.
A computed tomography (CT) scan, with intravenous
contrast, performed for staging revealed a large, well-
defined solid cum cystic lesion arising from the body and
tail of the pancreas (Figure-1). It measured 115 x 125mm,
the lesion was seen crossing the midline and abutting the
stomach and left kidney. The aorta was displaced towards
the right side. The left renal artery could not be separately
visualised. The lesion was causing encasement of the
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Figure-1: CT scan of the patient showing a well-defined solid cum cystic lesion arising
from the body and tail of the pancreas, crossing the midline to displace the
aorta towards the right and compressing the splenic vessels.
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splenic vessels resulting in the formation of splenic varices.
Ultrasound guided biopsy revealed neoplastic nature of the
mass with positive CD10 and PR immunohistochemical
stains indicating pseudopapillary tumour of the pancreas.
This case was later discussed in our institutional
multidisciplinary Paediatric tumour board meeting. As
there are no adjuvant treatment options for this pathology,
surgical excision was advised. Preoperatively the patient
received prophylactic vaccination for possible need for
splenectomy.
She underwent exploratory laparotomy plus distal
pancreatectomy with splenectomy and bowel anastomosis
in August 2019.
Intraoperatively, a large mass (15 x 15 cm) was found
arising from the distal pancreas (body and tail) adherent to
the middle part of the greater curvature of the stomach
(inseparable) and also adherent to and inseparable from
mesocolon in the region of middle colic artery. The tumour
was extending into the splenic hilum and was encasing the
splenic vessels; hence, no attempt was made to separate it
from the stomach, involved transverse colon and spleen.
We performed segmental resection of the greater
curvature of the stomach and transverse colon in the
region of middle colic artery. Later, functional end to end
anastomosis between two ends of the transverse colon was
made using GI stapler. A clear margin of pancreas (around
2cm) was achieved.
It was removed completely intact along with a portion of
the stomach, colon with its attached mesentery, and lymph
nodes and spleen. No tumour was left behind grossly and
there was no tumour spillage.
The patient’s postoperative course was unremarkable. She
was discharged in a stable condition on the seventh post-
operative day.
Final histopathology showed solid pseudopapillary
neoplasm of the pancreas. All margins were tumour
free.Final tumour grading was pT3, pN0. On the six-month
follow up visit our patient had no significant complaints
and was clinically well.
Discussion
Most SPNs are asymptomatic and incidentally found by
imaging. In some cases, the patients may present with
nonspecific symptoms, including abdominal discomfort,
nausea, vomiting, asthenia, or pain. In patients with large
neoplasms, acute abdomen resulting from traumatic intra
tumoural haemorrhage has been described. Tumour
markers’ serum levels are normal, so they are not useful in
the diagnostic workup. Rare SPNs have been found to be
associated with familial adenomatous polyposis.4-6
Cytological examination is usually the first and most used
approach in the diagnostic workup of pancreatic solid and
cystic masses, so the first diagnosis of SPN is frequently
cytological. Because of its peculiar clinical and prognostic
features, a definitive and quick diagnosis of SPN is
mandatory to avoid aggressive surgery or chemotherapy.
Endoscopic ultrasound-guided fine-needle aspiration is the
most frequently used procedure, which in expert hands is
a safe, cost-effective, and valuable technique.7 Solid
pseudo papillary neoplasm is a solitary tumour. In adults,
it is slightly more frequently located in the tail, whereas in
children it is located in the pancreatic head. Tumours are
round, well demarcated, and generally large, with an
average size of 8 to 10cm (range, 0.5–25.0 cm). The cut
surface shows a variable appearance from case to case:
some cases are completely cystic, whereas others show a
variable combination of solid, cystic, haemorrhagic, and
necrotic areas. More rarely, SPNs have a predominantly
solid appearance, especially when small. Although
generally well-circumscribed, rare tumours extending into
the duodenal wall or other adjacent structures have been
reported.8,9
It is well known that tumour cells characteristically show
nuclear/cytoplasmic immunoreactivity for b-catenin. In
addition, they are also positive for CD10, progesterone
receptor, cyclin D1, and vimentin. A very characteristic
feature is represented by the immunoreactivity of CD99
that shows a peculiar dot-like para-nuclear expression.
Aberrant expression of E-cadherin is a typical feature of
SPN, and two distinct patterns of immunoreactivity have
been well-documented and depend on the antibody
used.10,11
Figure-2:  Post-operative picture showing the tumour adherent to the spleen, greater
curvature of the stomach and transverse colon.
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Function-preserving surgery is advocated as a treatment of
SPN. Liu et al reported 243 patients (181 females and 62
males) who underwent complete resection. A total of 239
patients were free of local recurrence or distant metastasis
after a median follow-up of 46 months.12
In another study Tjaden et al analysed 52 patients out of
which 85% were females. Seven patients exhibited a
malignant behaviour of SPN whereas five patients
developed recurrence of tumour, after a median follow-up
of 21 months. All the patients were alive during the follow-
up time (median 54 months), the 5- and 10-year rates for
disease-free survival were 89.0% and 81.6%, respectively.13
The minimally invasive approach with its better short-term
perioperative outcomes carries immense functional
benefits in addition to the quality-of-life such as better pain
control, decreased analgesic requirement, increased early
ambulation, and shorter duration of ileus, compared with
the open approach. The results of meta-analysis published
by Tan et al favours minimally invasive surgery over open
approach as far as intraoperative blood loss and blood
transfusion requirements are concerned, which may be due
to the smaller incisions and finer operative dissections used
in minimally invasive surgery.14
SPN shows a favourable prognosis, but is not yet fully
understood regarding its biological behaviour and factors
that are associated with tumour spread or recurrence.
Conclusion
Solid pseudopapillary neoplasm of the pancreas is
manifested as large, encapsulated mass, usually with
extensive necrosis. An aggressive approach with complete
surgical resection, is recommended. Poor long-term
prognosis is seen in patients with incomplete resection,
even though the tumours are very slow-growing. 
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